Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by MPH Acquisition Holdings LLC, a wholly owned subsidiary of MultiPlan…
Davis Polk advised the representative of the initial purchasers in connection with the debut Rule 144A/Regulation S offering by LD Holdings Group LLC of $500 million aggregate principal…
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion initial public offering of 54,625,000 shares of common…
Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare Company, Inc. of $475 million aggregate principal amount of…
Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance III, LLC, a wholly owned subsidiary of LyondellBasell Industries N.V., of $500…
Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Holdings, Inc. of $800 million aggregate principal…
Davis Polk advised the joint book-running managers in connection with an offering by Advance Auto Parts, Inc. of $350 million aggregate principal amount of its 1.750% notes due 2027…
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Hologic, Inc. of $950 million aggregate principal amount of its…
Davis Polk advised the representatives of the initial purchasers in a Rule 144A offering by Omnicell, Inc. of $575 million aggregate principal amount of 0.25% convertible senior notes due…